Morningstar - Dominion Energy Inc (D) Time Is Ticking in Scanas Favor

Report

Morningstar

Charles Fishman

Time Is Ticking in Scana's Favor

We are reaffirming our $57 per share fair value estimate for Scana as South Carolina politicians remain at loggerheads and a regulatory decision on Dominion's acquisition proposal is likely set for late December.
South Carolina politicians last week were unable to reconcile the House's 18% temporary rate-cut bill and the Senate's 13% temporary rate-cut bill. We expect the earliest a rate cut could be implemented is July, just six months before we expect a regulatory decision. Worst-case, we esti...

29/05/2018 18 EN

Underlying

Dominion Energy Inc

Dominion Energy is a holding company. Through its subsidiaries , the company is engaged in producing and transporting energy. The company's operations are conducted through its subsidiaries: Virginia Electric and Power Company, which is a regulated public utility that generates, transmits and distributes electricity for sale in Virginia and North Carolina; and Dominion Energy Gas Holdings, LLC, which serves as the intermediate parent company for the company's Federal Energy Regulatory Commission-regulated interstate natural gas transmission pipeline and underground storage systems in the eastern and Rocky Mountain regions, as well as for the liquefied natural gas import/export and storage facility.

See profile

US25746U1097 New York Stock Exchange United States

Provider

Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

See profile

Analysts

Charles Fishman

Other Reports on these Companies

Vermilion Research

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

EUR 43.00

February 25, 2025 February 25, 2025 1 EN

Moody's Investors Service

Dominion Energy, Inc.: Higher cost of Coastal Virginia Offshore Wind will increase debt, limit cash recovery prospects and raise social risks

Updated costs will increase debt financing for the project and expose the company to costs that will not be recovered, while increasing political and regulatory scrutiny.

EUR 172.00

February 5, 2025 February 5, 2025 1 EN

Moody's Investors Service

Moody's Ratings affirms Dominion Resources Capital Trust III's Baa3 rating; outlook stable

Moody's Ratings (Moody's) today affirmed the Baa3 backed preferred stock rating of Dominion Resources Capital Trust III (DRCT). The outlook for Dominion Resources Capital Trust III remains stable. RATINGS RATIONALE Dominion Resources Capital Trust III (DRCT)'s preferred stock is one notch below ...

EUR 154.80

January 23, 2025 January 23, 2025 1 EN

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Contract manufacturer Lonza reported solid half-year results, with over CHF 2.9 billion in total sales year to date, up about 6.4% from last year and boosted by foreign exchange tailwinds. Core EBITDA margin expanded 30 basis points from last year to about 27.8%, helped slightly by new accounting standards. Management indicated that it continues to expect mid- to high-single-digit sales growth in 2019. We are maintaining our fair value estimate of CHF 210 per share and our no-moat rating. The ph...

EUR 100.00

July 25, 2019 July 25, 2019 13 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

We don't expect any major changes to our AstraZeneca fair value estimate following second-quarter results that largely fell in line with our expectations and slightly ahead of consensus expectations. Overall, the company is posting leading Big Pharma sales growth with total sales up 18% operationally year over year, led by impressive cancer drug sales growth of 57%. Astra's ability to continue to bring next generation drugs to the market that address unmet medical need (especially in oncology) s...

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Time Is Ticking in Scana's Favor

Vital Signs: Actionable charts

Dominion Energy, Inc.: Higher cost of Coastal Virginia Offshore Wind will increase debt, limit cash recovery prospects and raise social risks

Moody's Ratings affirms Dominion Resources Capital Trust III's Baa3 rating; outlook stable

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe